Signatures of DNA-Repair Deficiencies in Breast Cancer

A woman who receives a diagnosis of breast cancer today is half as likely to die from cancer as she was three decades ago, in part owing to treatments that target expression of the estrogen receptor and the cell-surface receptor HER2 (human epidermal growth factor receptor 2) in subtypes of…

http://ift.tt/2Djacwx